Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)

BACKGROUND: Preoperative chemoradiotherapy (CRT) with CROSS regimen has been the recommended treatment for locally advanced esophageal squamous cell carcinoma (ESCC). The addition of programmed cell death protein 1 (PD-1) inhibitor to preoperative CRT may further improve oncologic results. Preoperat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Zhu, Li, Cheng, Yan, Liu, Zhichao, Cai, Xiaoyue, Shao, Jinchen, Zhang, Ming, Liu, Jun, Sun, Yifeng, Li, Yin, Yi, Jun, Yu, Bentong, Jiang, Hongjing, Chen, Hezhong, Yang, Hong, Tan, Lijie, Li, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074348/
https://www.ncbi.nlm.nih.gov/pubmed/35524205
http://dx.doi.org/10.1186/s12885-022-09573-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074348/
https://www.ncbi.nlm.nih.gov/pubmed/35524205
http://dx.doi.org/10.1186/s12885-022-09573-6

Ejemplares similares